Stryker (NYSE:SYK) Hits New 12-Month Low – Time to Sell?

Stryker Corporation (NYSE:SYK)’s stock price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $328.23 and last traded at $338.2070, with a volume of 1622916 shares. The stock had previously closed at $345.78.

Trending Headlines about Stryker

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Citi and some analysts view the pullback as a potential buying opportunity given Stryker’s fundamentals and upcoming catalysts — Citi put together a “90‑day catalyst watch” that sees upside despite the outage. Citi Sees Upside
• Positive Sentiment: Technicals may offer support: commentators note shares became oversold after the sell‑off and found support at a prior level, suggesting a possible technical bounce for traders. Stock Of The Day: Where Is The Bottom For Stryker?
• Neutral Sentiment: Stryker has publicly confirmed a cybersecurity incident and is investigating; the company is communicating updates as the situation evolves. Company Announcement
• Neutral Sentiment: Reporting shows the attack is causing real operational disruption to order processing, manufacturing and shipments — facts investors must watch to judge duration and revenue impact. Reuters: Disruption Report
• Negative Sentiment: Hackers claiming Iran linkage (group “Handala”) say the attack included destructive “wiper” activity and exfiltration of large volumes of data — allegations that raise the risk of extended downtime and regulatory/PR fallout. IBTimes: Hacker Claim
• Negative Sentiment: Operational paralysis from the incident has already pressured the stock, with multiple outlets reporting multi‑percent intraday declines as orders and shipments stall. Yahoo: Shares Fall
• Negative Sentiment: Social‑media driven selling amplified volatility — a viral Reddit thread and related headlines accelerated the recent drop, adding short‑term downside risk beyond fundamentals. 24/7 Wall St.: Reddit Impact

Analysts Set New Price Targets

A number of equities research analysts have issued reports on SYK shares. William Blair reiterated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Royal Bank Of Canada reissued an “outperform” rating and set a $435.00 price objective on shares of Stryker in a report on Friday, November 14th. Piper Sandler reiterated an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Jefferies Financial Group reaffirmed a “buy” rating and set a $465.00 target price on shares of Stryker in a research report on Wednesday, March 4th. Finally, Citigroup restated a “market outperform” rating on shares of Stryker in a report on Friday, January 30th. Fourteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $428.61.

Stryker Stock Performance

The company has a 50-day moving average of $365.20 and a 200-day moving average of $367.71. The company has a market cap of $128.95 billion, a PE ratio of 40.11, a PEG ratio of 1.97 and a beta of 0.85. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. During the same quarter last year, the business posted $4.01 EPS. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. As a group, analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Tuesday, March 31st. Stryker’s payout ratio is 41.90%.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 5.90% of the company’s stock.

Institutional Trading of Stryker

Several hedge funds and other institutional investors have recently bought and sold shares of the company. World Investment Advisors boosted its position in Stryker by 0.7% during the fourth quarter. World Investment Advisors now owns 10,890 shares of the medical technology company’s stock valued at $3,828,000 after buying an additional 71 shares during the period. Corient Private Wealth LLC grew its holdings in shares of Stryker by 3.3% in the fourth quarter. Corient Private Wealth LLC now owns 981,354 shares of the medical technology company’s stock worth $345,023,000 after purchasing an additional 31,361 shares during the last quarter. Auto Owners Insurance Co increased its stake in shares of Stryker by 35,047.0% in the fourth quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after buying an additional 2,906,448 shares during the period. Union Savings Bank bought a new stake in Stryker during the 4th quarter valued at $1,157,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new stake in Stryker during the 4th quarter valued at $95,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.